Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biopsy, Fine-Needle | 3 | 2009 | 116 | 0.600 |
Why?
|
| Barrett Esophagus | 5 | 2014 | 339 | 0.390 |
Why?
|
| Breast Neoplasms, Male | 1 | 2009 | 15 | 0.330 |
Why?
|
| Carcinoma | 1 | 2009 | 285 | 0.270 |
Why?
|
| Bacterial Infections | 1 | 2008 | 305 | 0.240 |
Why?
|
| Felty Syndrome | 1 | 2023 | 2 | 0.220 |
Why?
|
| Hand Dermatoses | 1 | 2023 | 7 | 0.220 |
Why?
|
| Biopsy, Needle | 2 | 2015 | 229 | 0.220 |
Why?
|
| Sweet Syndrome | 1 | 2023 | 11 | 0.220 |
Why?
|
| Dermatitis | 1 | 2023 | 25 | 0.220 |
Why?
|
| Isoenzymes | 3 | 1999 | 228 | 0.220 |
Why?
|
| Protein Kinase C | 3 | 1999 | 150 | 0.220 |
Why?
|
| Skin Diseases | 1 | 2023 | 124 | 0.200 |
Why?
|
| Neutropenia | 1 | 2023 | 200 | 0.200 |
Why?
|
| Adenocarcinoma | 4 | 2011 | 1000 | 0.190 |
Why?
|
| Gastritis | 2 | 2017 | 371 | 0.190 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2002 | 141 | 0.180 |
Why?
|
| Colorectal Neoplasms | 3 | 2011 | 566 | 0.160 |
Why?
|
| Colon | 2 | 2007 | 353 | 0.140 |
Why?
|
| Breast | 2 | 2009 | 216 | 0.140 |
Why?
|
| Aged | 16 | 2017 | 19692 | 0.130 |
Why?
|
| Waist-Hip Ratio | 2 | 2013 | 56 | 0.130 |
Why?
|
| Diet | 2 | 2013 | 1137 | 0.130 |
Why?
|
| Helicobacter Infections | 3 | 2014 | 1264 | 0.120 |
Why?
|
| Aged, 80 and over | 9 | 2017 | 6521 | 0.120 |
Why?
|
| Amyloidosis | 1 | 2015 | 70 | 0.110 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 112 | 0.110 |
Why?
|
| Helicobacter pylori | 2 | 2014 | 1321 | 0.110 |
Why?
|
| Glycation End Products, Advanced | 1 | 2013 | 23 | 0.110 |
Why?
|
| Meat | 1 | 2013 | 48 | 0.110 |
Why?
|
| Diphosphonates | 1 | 2013 | 38 | 0.110 |
Why?
|
| Bone Density Conservation Agents | 1 | 2013 | 52 | 0.100 |
Why?
|
| Middle Aged | 12 | 2023 | 26717 | 0.100 |
Why?
|
| Osteoporosis | 1 | 2013 | 116 | 0.100 |
Why?
|
| Endoscopy, Digestive System | 4 | 2014 | 153 | 0.100 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2013 | 75 | 0.100 |
Why?
|
| Eosinophilia | 1 | 2013 | 101 | 0.090 |
Why?
|
| Logistic Models | 5 | 2014 | 1810 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 2044 | 0.090 |
Why?
|
| Vegetables | 1 | 2013 | 262 | 0.090 |
Why?
|
| Folic Acid | 1 | 2013 | 292 | 0.090 |
Why?
|
| Antioxidants | 1 | 2013 | 336 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 489 | 0.080 |
Why?
|
| Myocardium | 1 | 2015 | 1008 | 0.080 |
Why?
|
| Biopsy | 2 | 2012 | 1239 | 0.080 |
Why?
|
| Peripheral Nerves | 1 | 2009 | 85 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2014 | 3287 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2011 | 190 | 0.080 |
Why?
|
| Male | 16 | 2023 | 61283 | 0.080 |
Why?
|
| Psoas Muscles | 1 | 2008 | 5 | 0.080 |
Why?
|
| Muscle Neoplasms | 1 | 2008 | 21 | 0.080 |
Why?
|
| Mycobacterium Infections | 1 | 2008 | 31 | 0.070 |
Why?
|
| Thrombospondin 1 | 1 | 2007 | 23 | 0.070 |
Why?
|
| Risk Factors | 7 | 2017 | 10272 | 0.070 |
Why?
|
| Adult | 8 | 2017 | 29472 | 0.070 |
Why?
|
| Humans | 19 | 2023 | 124790 | 0.070 |
Why?
|
| Mycoses | 1 | 2008 | 116 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 299 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2012 | 1568 | 0.070 |
Why?
|
| Adenoma, Villous | 1 | 2006 | 2 | 0.070 |
Why?
|
| Anus Neoplasms | 1 | 2006 | 38 | 0.060 |
Why?
|
| Odds Ratio | 3 | 2013 | 1252 | 0.060 |
Why?
|
| Mammary Glands, Animal | 2 | 1999 | 482 | 0.060 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 3447 | 0.060 |
Why?
|
| Carcinoma, Medullary | 1 | 2004 | 15 | 0.060 |
Why?
|
| Hyperthyroidism | 1 | 2004 | 26 | 0.060 |
Why?
|
| Filgrastim | 1 | 2023 | 15 | 0.060 |
Why?
|
| Blister | 1 | 2023 | 19 | 0.060 |
Why?
|
| Female | 14 | 2017 | 66553 | 0.060 |
Why?
|
| Prevalence | 3 | 2017 | 2451 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2007 | 779 | 0.050 |
Why?
|
| Cytodiagnosis | 1 | 2002 | 18 | 0.050 |
Why?
|
| Hernia, Hiatal | 2 | 2013 | 54 | 0.050 |
Why?
|
| False Negative Reactions | 1 | 2002 | 89 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2007 | 1026 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2008 | 3061 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2009 | 1664 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2002 | 330 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 1008 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1999 | 1229 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2002 | 422 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 2090 | 0.040 |
Why?
|
| Lactation | 2 | 1999 | 194 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2002 | 803 | 0.040 |
Why?
|
| Lung | 1 | 2008 | 1491 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 1425 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 105 | 0.040 |
Why?
|
| Disease-Free Survival | 2 | 2011 | 868 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 258 | 0.040 |
Why?
|
| Rats | 3 | 1999 | 3689 | 0.040 |
Why?
|
| Blotting, Western | 1 | 1998 | 1110 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 1998 | 249 | 0.030 |
Why?
|
| Immunoglobulin Light-chain Amyloidosis | 1 | 2015 | 11 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1999 | 1001 | 0.030 |
Why?
|
| Texas | 2 | 2013 | 3590 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 151 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 1998 | 1929 | 0.030 |
Why?
|
| Etidronic Acid | 1 | 2013 | 9 | 0.030 |
Why?
|
| Alendronate | 1 | 2013 | 19 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 1998 | 776 | 0.030 |
Why?
|
| Dietary Fiber | 1 | 2013 | 74 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2013 | 3726 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2015 | 192 | 0.030 |
Why?
|
| Lysine | 1 | 2013 | 197 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2015 | 428 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 3338 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2014 | 238 | 0.020 |
Why?
|
| Health Surveys | 1 | 2012 | 244 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1690 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2011 | 137 | 0.020 |
Why?
|
| Prognosis | 2 | 2011 | 4608 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 2015 | 631 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2013 | 261 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 2013 | 294 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 410 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2008 | 16296 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2006 | 618 | 0.020 |
Why?
|
| Echocardiography | 1 | 2015 | 1052 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2012 | 485 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2015 | 974 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2009 | 143 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 1999 | 98 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2009 | 83 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2009 | 136 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2013 | 361 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 356 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 160 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 141 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 611 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2009 | 327 | 0.020 |
Why?
|
| Animals | 4 | 2007 | 34185 | 0.020 |
Why?
|
| Mice | 2 | 2007 | 17746 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 1028 | 0.020 |
Why?
|
| Spleen | 1 | 2007 | 282 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 266 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2007 | 710 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 1247 | 0.020 |
Why?
|
| Anal Canal | 1 | 2006 | 80 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 1228 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2007 | 380 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 2052 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2007 | 886 | 0.010 |
Why?
|
| Epithelial Cells | 2 | 1999 | 910 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 151 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 577 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 954 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 6137 | 0.010 |
Why?
|
| Veterans | 1 | 2013 | 1754 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2009 | 12342 | 0.010 |
Why?
|
| Obesity | 1 | 2012 | 2278 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1999 | 103 | 0.010 |
Why?
|
| Sexual Maturation | 1 | 1999 | 48 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1999 | 137 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1999 | 124 | 0.010 |
Why?
|
| United States | 1 | 2013 | 10880 | 0.010 |
Why?
|
| Milk | 1 | 1998 | 119 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 4357 | 0.010 |
Why?
|
| Organoids | 1 | 1999 | 284 | 0.010 |
Why?
|
| Pregnancy | 2 | 1999 | 7172 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1998 | 867 | 0.010 |
Why?
|